FDA Approves New Extended-Release Parkinson's Medication

This chapter explores the FDA's approval of Crexant, an extended-release medication for Parkinson's disease aimed at enhancing motor function. It highlights key findings from the RISE PD trial and discusses the formulation and clinical availability of the drug.